There is nearly complete overlap of MSI‐H or aberrant expression of MLH1, MSH2, MSH6, or PMS2 with EMAST positivity and our findings do no indicate that EMAST differentiates MSI‐H tumours into two subgroups. The gene discussed is MSH2; the disease is neoplasm.